title: The efficacy of multiple risk factor intervention in treated hypertensive men during long-term follow up. Risk Factor Intervention Study Group.
abstract: OBJECTIVE
  To examine the feasibility and efficacy of a multifactorial intervention programme directed towards hypercholesterolaemia, smoking, and diabetes mellitus in treated hypertensive patients after more than 3 years' follow-up and to describe the incidence of cardiovascular complications.
  
  
  METHODS
  Open, randomized, parallel-group study with allocation either to a comprehensive multiple risk factor modification programme or to usual care.
  
  
  METHODS
  Outpatient clinic in a city hospital.
  
  
  METHODS
  A total of 508 male patients with treated hypertension, aged 50-72 years, with at least one of the following: serum cholesterol > or = 6.5 mmol L-1, smoking or diabetes mellitus.
  
  
  METHODS
  Individually given advice and group meetings based on nutritional advice and behavioral treatment principles. Drug therapy could be instituted to achieve the treatment goals in the intervention group: serum total cholesterol below 6.0 mmol L-1, no smoking, and HbA1c below 6.0%. Diastolic blood pressure below 90 mmHg was the treatment goal in both groups.
  
  
  METHODS
  Serum cholesterol, HbA1c, diastolic blood pressure, smoking. Cardiovascular end-points were recorded.
  
  
  RESULTS
  The net changes were (change intervention--change usual care): serum cholesterol -5.0% (95% confidence interval, -7.6 to -2.3%), 17.6% more stopped smoking (P = 0.04); diastolic blood pressure and HbA1c remained unchanged. The incidence of stroke was lower in the intervention group compared with the usual-care group: 2.0 and 6.7%, respectively (P = 0.017).
  
  
  CONCLUSIONS
  The intervention programme was comparatively successful with regards to the effects on hypercholesterolaemia and smoking habits. An unexpected decrease in the stroke incidence was observed in the intervention group compared with the usual-care group.
authors.affiliation: Department of Medicine, Sahlgrenska University Hospital, Göteborg University, Sweden.
authors.forename: S
authors.initials: S
authors.lastname: Agewall
authors.forename: J
authors.initials: J
authors.lastname: Wikstrand
authors.forename: O
authors.initials: O
authors.lastname: Samuelsson
authors.forename: B
authors.initials: B
authors.lastname: Persson
authors.forename: O K
authors.initials: OK
authors.lastname: Andersson
authors.forename: B
authors.initials: B
authors.lastname: Fagerberg
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood / Q000628:therapy*; D005240:Feasibility Studies; D005500:Follow-Up Studies; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000628:therapy*; D006973:Hypertension / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects / Q000097:blood / Q000628:therapy*; D016896:Treatment Outcome